| NDC Code: |
33332-013 |
| Proprietary Name: |
AFLURIA |
| Suffix: |
|
| Non-Proprietary Name: |
INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED) |
| Dosage Form: |
INJECTION, SUSPENSION |
| Method: |
INTRAMUSCULAR |
| Original Marketing Date: |
15-07-2011 |
| End of Marketing: |
30-06-2014 |
| Category Name: |
BLA |
| Application Number: |
BLA125254 |
| Labeler: |
CSL LIMITED |
| Substance Name: |
INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED) |
| Active Numerator Strength: |
15; 15; 15 |
| Active Ingredient Unit: |
ug/.5mL; ug/.5mL; ug/.5mL |
| Pharm Classes: |
Inactivated Influenza A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Influenza Vaccines [Chemical/Ingredient] |
| DEA Schedule: |
|
